Stanley Erck, Novavax CEO (Andrew Harnik, AP Images)

Stan­ley Er­ck bagged $48M in pay as he guid­ed No­vavax on a re­mark­able turn­around in the hunt for a Covid-19 vac­cine

Among pan­dem­ic suc­cess sto­ries, on­ly Mod­er­na ri­vals Mary­land-based No­vavax’s re­mark­able rise from the bow­els of ob­scu­ri­ty to vac­cine play­er. Dri­ving that change was CEO Stan­ley Er­ck, who helped build the biotech’s sup­ply chain from scratch — and he was paid hand­some­ly to do it.

Er­ck scored a $48 mil­lion pay pack­age in 2020, un­der­scored by his work lead­ing No­vavax from near-bank­rupt­cy to one of the re­main­ing fron­trun­ners for a Covid-19 vac­cine, ac­cord­ing to an SEC fil­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.